10% Enrofloxacin Oral Ngwọta
.png)
.png)
.png)
.png)
Ihe mejupụtara
100 ml nwere 10 g nke Enrofloxacin
Ọdịdị
Ngwaahịa a fọrọ nke nta ka ọ ghara ịdị na-acha ka ọ bụrụ mmiri mmiri na-acha odo odo
Pharmacological omume
Empagliflozin bụ ọgwụ nje na-egbu egbu nke a raara nye fluoroquinolones.Ọ na-enwe mmetụta dị mma na Escherichia coli, Salmonella, Klebsiella, Brucella, Pasteurella, Actinobacillus pleuropneumoniae, Erysipelothrix, Proteus, Serratia marcescens, Corynebacterium pyogenes, Potter septicum, Staphylococcus aureus, Mycoplasma na-adịghị ike, Staphylococcus aureus, Mycoplasma, na ike onunu ogwu. na mmetụta na-adịghị ike na nje bacteria anaerobic.Ọ nwere mmetụta dị ịrịba ama post-antibacterial na nje bacteria nwere ike ime.Usoro nje antibacterial nke ngwaahịa a bụ igbochi nje DNA gyrase, gbochie mmegharị, idegharị na nrụzi na nchikota DNA nke nje bacteria, na nje bacteria enweghị ike itolite na ịmụba nke ọma wee nwụọ.
Pharmacokinetics
Ngwaahịa a na-etinye obi gị dum nke ọma mgbe nchịkwa ọnụ gasịrị n'ọtụtụ anụmanụ.The bioavailability nke ọnụ nchịkwa na ọkụkọ bụ 62.2% ~ 84%, nke a na-ekesa n'ọtụtụ ebe na anụ ọkụkọ na ike ịbanye anụ ahụ na mmiri mmiri (gụnyere ọkpụkpụ).Ewezuga mmiri mmiri cerebrospinal, ntinye ọgwụ n'ihe fọrọ nke nta ka ọ bụrụ anụ ahụ niile dị elu karịa na plasma.Metabolism imeju na-abụkarị iwepu ethyl otu nke 7-piperazine mgbanaka iji mepụta ciprofloxacin, na-esote oxidation na glucuronic acid conjugation.A na-ewepụ ya nke ọma site na akụrụ (ya na secretion tubular na glomerular filtration), na 15% ruo 50% na-ewepụ ya na-agbanweghị na mmamịrị.Mwepụ ọkara ndụ ngwaahịa a mgbe nchịkwa ọnụ na ọkụkọ bụ awa 9.1 ruo 14.2.
Mmekọrịta ọgwụ
(1) Ngwaahịa a nwere mmetụta synergistic yana njikọta na aminoglycosides ma ọ bụ penicillins sara mbara.
Ion ígwè dị arọ dị ka Ca2 +, Mg2 +, Fe3 + na Al3 + nwere ike iji ngwaahịa a chelate ma metụta nnabata.
(2) Mgbe ejikọtara ya na theophylline na caffeine, enwere ike ibelata ọnụego njikọ protein plasma, mkpokọta theophylline na caffeine nwere ike ịbawanye ụba nke ukwuu, na ọbụna ihe mgbaàmà nke nsị theophylline nwere ike ime.
(3) Ngwaahịa a nwere mmetụta nke igbochi imeju ọgwụ enzymes, nke nwere ike ibelata mkpochapụ ọnụego nke ọgwụ tumadi metabolized na imeju na-abawanye na plasma ịta.
(4) Omume na ojiji: Fluoroquinolone ọgwụ nje.A na-eji ya maka ọrịa nje na ọrịa mycoplasma na ọkụkọ.
Usoro onunu ogwu na nchịkwa
Ihe ọṅụṅụ agwakọtara: 0.5 ~ 0.75 ml maka anụ ọkụkọ kwa 1 l mmiri.
Mmeghachi omume ọjọọ
(1) Mmebi nke cartilage na-eme n'ime ụmụ anụmanụ na-eto eto, na-emetụta ọkpụkpụ ọkpụkpụ ma na-eme ka ngwọrọ na mgbu.
(2) Mmeghachi omume usoro mgbari nri gụnyere enweghị agụụ, afọ ọsịsa, wdg.
Mkpachapụ anya
Ọ bụ contraindicated na Ịtọ hens n'oge Ịtọ oge
Oge mwepụ
Avian: 8 ụbọchị
Nchekwa
Akara ma chekwaa, chebe ya pụọ na ìhè.
Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.
Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.
Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.
